Trial
NCT05105412
Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
National Health Research Institutes, Taiwan
Collaborators
National Taiwan University Hospital; Chang Gung Memorial Hospital; National Cheng-Kung University Hospital; China Medical University Hospital
Condition
Peripheral T-cell Lymphomas (PTCL)
Intervention
Lenalidomide and Gemcitabine (Dose level 11)
Why stopped
The resolution of DSMB
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-08